Tempest Therapeutics Ownership | Who Owns Tempest Therapeutics?


OverviewForecastFinancialsChart

Tempest Therapeutics Ownership Summary


Tempest Therapeutics is owned by 7.69% institutional investors, 34.26% insiders, and 58.05% retail investors. Versant venture management is the largest institutional shareholder, holding 6.08% of TPST shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.90% of its assets in Tempest Therapeutics shares.

TPST Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTempest Therapeutics7.69%34.26%58.05%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Versant venture management269.77K6.08%$774.25K
Blackrock550.24K2.47%$1.21M
Geode capital management86.99K2.10%$142.67K
Vanguard fiduciary trust68.91K1.66%$113.01K
Blackrock funding, inc. /de39.07K0.94%$64.07K
Fmr33.23K0.80%$54.49K
Susquehanna group, llp123.42K0.48%$103.00K
Sabby management17.86K0.43%$29.28K
Northern trust14.05K0.34%$23.05K
Dimensional fund advisors lp11.44K0.28%$18.77K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Versant venture management269.77K0.51%$774.25K
Sabby management17.86K0.07%$29.28K
Tower research capital llc (trc)2.79K0.00%$4.58K
National bank of canada /fi/---
Engineers gate manager lp---
Gsa capital partners llp---
Drw securities---
Blackrock550.24K-$1.21M
Fil---
Parallel advisors18.00-$30.00

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp123.42K-78.16K
Vanguard fiduciary trust68.91K-68.91K
Geode capital management86.99K-42.88K
Blackrock550.24K-42.05K
Citadel advisors29.60K-16.10K

Top Sellers

HolderShares% AssetsChange
Altium capital management lp---545.00K
Jane street group---493.09K
Vanguard group---297.88K
Millennium management---189.51K
Xtx topco---160.81K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust68.91K-68.91K$113.01K
Vanguard global advisers168.00-168.00$276.00
Citigroup8.00-8.00$13.00
Jpmorgan chase5.00-5.00$8.00
Global retirement partners5.00-5.00$4.00

Sold Out

HolderChange
Whittier trust-2.00
Whittier trust co of nevada-11.00
Qube research-27.00
Wells fargo & company/mn-98.00
Cibc private wealth group-133.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20269-55.00%319,026-59.49%72.13%4-50.00%1-75.00%
Dec 31, 20251-269,772-612.07%----
Sep 30, 20251-50.00%269,772-8.70%711.75%--100.00%--
Jun 30, 20252-92.00%295,494-88.08%725.24%1-90.91%--100.00%
Mar 31, 202525-32.43%2,479,851-63.43%50.80%12-45.45%2-50.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr128.94K0.90%-
Vanguard Total Stock Mkt Idx Inv104.94K0.73%-
Fidelity Extended Market Index60.30K0.42%35.98K
Abante Quant Value FI41.82K0.29%-
BlackRock Extended Equity Market K36.10K0.14%-15.00
iShares Micro-Cap ETF3.46K0.10%-
Spartan Extended Market Index Pool E41.04K0.09%1.93K
Spartan Extended Market Index Pool F12.07K0.08%6.99K
Northern Trust Extended Eq Market Idx10.94K0.08%6.41K
NT Ext Equity Mkt Idx Fd - L10.94K0.08%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 24, 2026Angel Matthew CEO and PresidentBuy$500.00K
Aug 12, 2024Versant Venture Capital VI, L.P.-Sell$426.99K
Aug 08, 2024Versant Venture Capital VI, L.P.-Sell$540.04K
Jul 03, 2024Brady Stephen R President and CEOBuy$73.85K
Jul 02, 2024Whiting Samuel Chief Medical OfficerBuy$9.95K

Insider Transactions Trends


DateBuySell
2026 Q11-
2025 Q1--
2024 Q322
2024 Q21-
2024 Q1--

TPST Ownership FAQ


Who Owns Tempest Therapeutics?

Tempest Therapeutics shareholders are primarily institutional investors at 7.69%, followed by 34.26% insiders and 58.05% retail investors. The average institutional ownership in Tempest Therapeutics's industry, Biotech Stocks , is 35.75%, which Tempest Therapeutics falls below.

Who owns the most shares of Tempest Therapeutics?

Tempest Therapeutics’s largest shareholders are Versant venture management (269.77K shares, 6.08%), Blackrock (550.24K shares, 2.47%), and Geode capital management (86.99K shares, 2.10%). Together, they hold 10.65% of Tempest Therapeutics’s total shares outstanding.

Does Blackrock own Tempest Therapeutics?

Yes, BlackRock owns 2.47% of Tempest Therapeutics, totaling 550.24K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.21M$. In the last quarter, BlackRock increased its holdings by 42.05K shares, a 8.27% change.

Who is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested?

Versant venture management is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.51% of its assets in 269.77K Tempest Therapeutics shares, valued at 774.25K$.

Who is the top mutual fund holder of Tempest Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Tempest Therapeutics shares, with 0.90% of its total shares outstanding invested in 128.94K Tempest Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools